EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 85 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,691,603 | -7.5% | 211,715 | +0.7% | 0.00% | – |
| Q2 2023 | $1,829,645 | +200.7% | 210,304 | +1.6% | 0.00% | – |
| Q1 2023 | $608,383 | -14.7% | 206,933 | +1.5% | 0.00% | – |
| Q4 2022 | $713,314 | -56.9% | 203,804 | -2.7% | 0.00% | – |
| Q3 2022 | $1,656,000 | -1.7% | 209,415 | -2.2% | 0.00% | – |
| Q2 2022 | $1,685,000 | -33.6% | 214,049 | +2.5% | 0.00% | – |
| Q1 2022 | $2,538,000 | +11.5% | 208,845 | +12.3% | 0.00% | – |
| Q4 2021 | $2,277,000 | +13.3% | 186,027 | -3.5% | 0.00% | – |
| Q3 2021 | $2,009,000 | +220.4% | 192,828 | +176.3% | 0.00% | – |
| Q2 2021 | $627,000 | +35.4% | 69,783 | +53.3% | 0.00% | – |
| Q1 2021 | $463,000 | +372.4% | 45,521 | +205.0% | 0.00% | – |
| Q4 2020 | $98,000 | – | 14,925 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,190,921 | $36,461,013 | 27.59% |
| ACUTA CAPITAL PARTNERS, LLC | 382,000 | $3,323,400 | 2.25% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,423,897 | $29,787,904 | 1.59% |
| Cormorant Asset Management, LP | 3,200,000 | $27,840,000 | 1.56% |
| Caligan Partners LP | 310,298 | $2,699,593 | 1.52% |
| Samsara BioCapital, LLC | 432,000 | $3,758,400 | 0.66% |
| RA Capital Management | 3,370,506 | $29,323,402 | 0.55% |
| SECTORAL ASSET MANAGEMENT INC | 311,277 | $2,708,110 | 0.45% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 209,949 | $1,826,556 | 0.26% |
| BARD ASSOCIATES INC | 30,674 | $266,864 | 0.10% |